Toshio Imai Selected Research

Animal Disease Models

4/2021	Serum APOA4 Pharmacodynamically Represents Administered Recombinant Human Hepatocyte Growth Factor (E3112).
6/2005	[Fractalkine and inflammatory diseases].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshio Imai Research Topics

Disease

46	Carcinogenesis 07/2022 - 01/2002
44	Neoplasms (Cancer) 07/2022 - 01/2002
20	Body Weight (Weight, Body) 07/2022 - 07/2002
14	Inflammation (Inflammations) 08/2021 - 03/2004
13	Carcinoma (Carcinomatosis) 01/2022 - 01/2002
13	Rheumatoid Arthritis 07/2021 - 11/2002
13	Adenocarcinoma 01/2021 - 01/2002
9	Hyperplasia 01/2019 - 06/2003
8	Adenoma (Adenomas) 08/2013 - 08/2003
6	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 08/2003
6	Pancreatic Neoplasms (Pancreatic Cancer) 01/2015 - 07/2010
4	Atherosclerosis 11/2020 - 01/2004
4	Colitis 01/2019 - 06/2006
4	Halitosis 11/2010 - 02/2008
4	Periodontitis 11/2010 - 01/2003
3	Crohn Disease (Crohn's Disease) 08/2021 - 11/2017
3	Arthritis (Polyarthritis) 05/2021 - 05/2017
3	Interstitial Lung Diseases (Interstitial Lung Disease) 05/2021 - 03/2012
3	Stomach Neoplasms (Stomach Cancer) 01/2020 - 03/2004
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2019 - 09/2009
3	Aberrant Crypt Foci 08/2011 - 08/2003
3	Hypertrophy 06/2009 - 06/2003
2	Breast Neoplasms (Breast Cancer) 10/2021 - 01/2003
2	Animal Disease Models 04/2021 - 06/2005
2	Rheumatic Diseases (Rheumatism) 11/2020 - 01/2020
2	Dermatomyositis (Dermatopolymyositis) 11/2020 - 03/2012
2	Fibrosis (Cirrhosis) 11/2019 - 02/2015
2	Experimental Arthritis 01/2019 - 12/2004
2	Synovitis 01/2019 - 05/2005
2	Osteoarthritis 12/2017 - 11/2002
2	Polymyositis 11/2017 - 03/2012
2	Papilloma (Papillomatosis) 01/2017 - 03/2009
2	Adenocarcinoma of Lung 11/2014 - 09/2003
2	Colonic Neoplasms (Colon Cancer) 07/2013 - 07/2013
2	Bone Resorption 11/2010 - 12/2009
2	Necrosis 08/2009 - 06/2009
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2009 - 09/2003

Drug/Important Bio-Agent (IBA)

21	Chemokine CX3CL1IBA 08/2021 - 01/2004
12	Monoclonal AntibodiesIBA 08/2021 - 12/2010
11	ChemokinesIBA 08/2021 - 03/2004
10	Drinking WaterIBA 01/2017 - 08/2003
10	diisopropanolnitrosamineIBA 06/2012 - 03/2004
6	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2008
6	CarcinogensIBA 07/2022 - 12/2002
6	anthraceneIBA 10/2021 - 01/2005
6	quetmolimabIBA 08/2021 - 01/2018
6	9,10-Dimethyl-1,2-benzanthraceneIBA 05/2013 - 07/2002
6	SulfadimethoxineIBA 06/2012 - 03/2004
5	Codon (Codons)IBA 10/2021 - 09/2003
5	Pharmaceutical PreparationsIBA 06/2021 - 02/2019
5	nitrosobis(2-oxopropyl)amine (NBOP)IBA 10/2018 - 07/2010
5	Messenger RNA (mRNA)IBA 01/2015 - 11/2004
5	SDMIBA 06/2012 - 03/2004
4	AdipokinesIBA 10/2018 - 11/2011
4	Indomethacin (Indometacin)FDA LinkGeneric 11/2012 - 06/2006
4	Antithyroid Agents (Antithyroid Drugs)IBA 06/2012 - 03/2004
4	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 11/2010 - 12/2009
4	Dextrans (Dextran)FDA Link 10/2007 - 08/2003
4	sodium sulfate (sodium bisulfate)FDA LinkGeneric 10/2007 - 08/2003
3	Biological ProductsIBA 07/2022 - 01/2005
3	IntegrinsIBA 01/2022 - 03/2011
3	2- amino- 1- methyl- 6- phenylimidazo(4,5- b)pyridineIBA 10/2021 - 01/2002
3	LigandsIBA 05/2021 - 11/2002
3	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2009
3	Cisplatin (Platino)FDA LinkGeneric 04/2020 - 01/2020
3	AzoxymethaneIBA 01/2019 - 08/2011
3	CX3C Chemokine Receptor 1IBA 11/2017 - 05/2005
3	CytokinesIBA 07/2013 - 11/2002
3	Corn Oil (Oil, Corn)IBA 05/2013 - 04/2008
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 03/2013 - 03/2007
3	LeptinIBA 01/2012 - 08/2011
3	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 02/2010 - 12/2005
3	Capsules (Microcapsules)IBA 10/2009 - 03/2004
3	1,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA 10/2007 - 08/2003
3	Dimenhydrinate (DMH)FDA LinkGeneric 10/2007 - 08/2003
2	Complement System Proteins (Complement)IBA 12/2022 - 07/2013
2	CateninsIBA 07/2022 - 07/2013
2	Estrogen ReceptorsIBA 10/2021 - 05/2013
2	Phenobarbital (Luminal)FDA Link 10/2021 - 01/2021
2	Transforming Growth Factor-beta Type II ReceptorIBA 01/2021 - 01/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2020
2	Tartrate-Resistant Acid PhosphataseIBA 01/2019 - 08/2009
2	AminesIBA 05/2018 - 01/2002
2	Urethane (Ethyl Carbamate)IBA 08/2013 - 11/2012
2	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 08/2013 - 05/2012
2	AcidsIBA 08/2013 - 05/2012
2	cyclo(arginylglycyl)IBA 08/2013 - 05/2012
2	Leptin ReceptorsIBA 05/2013 - 08/2011
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2013 - 01/2005
2	nimesulide (Aulin)IBA 06/2012 - 02/2006
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 06/2012 - 01/2005
2	potassium perchlorate FDA Link 03/2009 - 01/2006
2	perilla seed oilIBA 04/2008 - 01/2002

Therapy/Procedure

4	Therapeutics 11/2020 - 09/2007
4	Ovariectomy (Oophorectomy) 01/2007 - 07/2002
3	Subcutaneous Injections 11/2019 - 08/2003
3	Aftercare (After-Treatment) 01/2019 - 07/2013
2	Transplantation 01/2022 - 10/2014
2	Drug Therapy (Chemotherapy) 04/2020 - 01/2015
2	Intraperitoneal Injections 08/2013 - 11/2012